Company · CIK 1827506

# Tourmaline Bio, Inc.

| CIK | [1827506](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001827506) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | NY |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-06-14 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-255316 | IPO Final prospectus | 2021-04-16 | 2025-11-14 | 5 |
| 333-283078 | Shelf Effective | 2024-11-07 | 2025-11-14 | 3 |
| 333-266875 | Shelf Effective | 2022-08-15 | 2024-01-26 | 4 |

## Filings

 14

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-11-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1827506/999999999525003289/9999999995-25-003289-index.htm) Declared effective | 333-283078 | 9999999995-25-003289 |
| 2025-11-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1827506/999999999525003283/9999999995-25-003283-index.htm) Declared effective | 333-255316 | 9999999995-25-003283 |
| 2024-11-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1827506/999999999524003490/9999999995-24-003490-index.htm) Declared effective | 333-283078 | 9999999995-24-003490 |
| 2024-11-07 | [S-3](https://www.sec.gov/Archives/edgar/data/1827506/000182750624000099/0001827506-24-000099-index.htm) Shelf registered | 333-283078 | 0001827506-24-000099 |
| 2024-01-26 | [424B5](https://www.sec.gov/Archives/edgar/data/1827506/000119312524016713/0001193125-24-016713-index.htm) Shelf takedown | 333-266875 | 0001193125-24-016713 |
| 2024-01-25 | [424B5](https://www.sec.gov/Archives/edgar/data/1827506/000119312524014541/0001193125-24-014541-index.htm) Shelf takedown | 333-266875 | 0001193125-24-014541 |
| 2023-09-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1827506/999999999523002663/9999999995-23-002663-index.htm) Declared effective | 333-273335 | 9999999995-23-002663 |
| 2022-08-25 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1827506/999999999522002502/9999999995-22-002502-index.htm) Declared effective | 333-266875 | 9999999995-22-002502 |
| 2022-08-15 | [S-3](https://www.sec.gov/Archives/edgar/data/1827506/000119312522221286/0001193125-22-221286-index.htm) Shelf registered | 333-266875 | 0001193125-22-221286 |
| 2021-05-10 | [424B4](https://www.sec.gov/Archives/edgar/data/1827506/000119312521156269/0001193125-21-156269-index.htm) Final prospectus | 333-255316 | 0001193125-21-156269 |
| 2021-05-06 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1827506/999999999521001826/9999999995-21-001826-index.htm) Declared effective | 333-255316 | 9999999995-21-001826 |
| 2021-05-03 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1827506/000119312521146474/0001193125-21-146474-index.htm) Amendment | 333-255316 | 0001193125-21-146474 |
| 2021-04-16 | [S-1](https://www.sec.gov/Archives/edgar/data/1827506/000119312521119531/0001193125-21-119531-index.htm) Registration filed | 333-255316 | 0001193125-21-119531 |
| 2021-02-26 | [DRS](https://www.sec.gov/Archives/edgar/data/1827506/000095012321003174/0000950123-21-003174-index.htm) Draft made public | 377-04319 | 0000950123-21-003174 |

[All filings of this company](https://equitycapital.markets/filings?cik=1827506) · [CSV](https://equitycapital.markets/filings.csv?cik=1827506)

---
Source page: https://equitycapital.markets/company/1827506 · Data: U.S. SEC EDGAR · CC BY 4.0